Mochida Pharmaceutical Co.,Ltd.
持田製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4534
FY2025 · 2026-03-31
| Gross margin | 48.1% |
| Operating margin | 8.7% |
| Net margin | 6.8% |
| Return on equity | 6.2% |
| Return on assets | 4.3% |
| Revenue growth (YoY) | 11.2% |
| EPS (basic) | ¥222.96 |
| EPS growth (YoY) | 39.0% |
| Current ratio | 4.29x |
| Equity ratio | 69.5% |
| Book value / share | ¥3,958.46 |
| Free cash flow | — |